Pfizer, Aurobindo Reach Accord In Lipitor Patent Case

Law360, New York (November 7, 2011, 8:34 PM EST) -- Pfizer Inc. and Aurobindo Pharma Ltd. reached a settlement agreement Monday that wraps up a patent infringement case Pfizer brought over Aurobindo's efforts to horn in on the market for its blockbuster cholesterol drug Lipitor.

The parties filed a joint motion to dismiss in Delaware federal court, saying they had entered into the agreement on Nov. 2 and asked U.S. District Judge Leonard P. Stark to dismiss all claims and counterclaims.

“This dismissal shall not act as an adjudication on the merits,” the motion said....
To view the full article, register now.